Matches in SemOpenAlex for { <https://semopenalex.org/work/W2553981149> ?p ?o ?g. }
- W2553981149 abstract "Abstract Background: Myelodysplastic syndromes (MDS) are associated with cytogenetic clones. To follow the maturation sequence of original clones and evolved subclones with additional cytogenetic abnormalities, progenitor cells, immature and mature myeloid cells were sorted by flow cytometry and analyzed separately by fluorescence in situ hybridization (FISH) and comparative genomic hybridization (CGH). Methods: Flow cytometry sorted cell fractions from bone marrows for sixteen patients with MDS-associated cytogenetic abnormalities were evaluated by FISH. Flow cytometric cell sorting was based on CD34+/low side scatter (SS) for progenitors, CD13+/CD16-/high SS for immature myeloid cells, and CD13+/CD16+/high SS for mature myeloid cells. Customized color labeling (spectrum orange, green and aqua) of FISH probe combinations were designed to detect and to analyze clonal evolution for each patient based on their known cytogenetic abnormalities and clonal evolution patterns. Three marrow aspirates were sorted for analysis by SNP/CGH microarray. Results: The 16 bone marrow specimens evaluated by FISH were categorized into three groups: (1) eight patients with a single, good-to-intermediate cytogenetic abnormality; (2) four patients with monosomy 7; and (3) four patients with more than one chromosome abnormality with evidence of clonal evolution by conventional cytogenetic analysis, excluding monosomy 7. The Group-1 abnormalities included deletion 20q (n=4), trisomy 8 (n=2), deletion 5q (n=1), and trisomy 11 (n=1). All specimens from this group showed FISH abnormalities in equal proportions in myeloid progenitors, immature and mature myeloid cells. Group-2 had four patients with monosomy 7. All four had monosomy 7 concentrated in the progenitor cells (45-79%) compared to immature and mature myeloid compartments (less than 9-36%). For Group-3, known original clones with single cytogenetic abnormalities (deletion 20q, monosomy 3, deletion 7q or 5q) were monitored by FISH analysis. Using customized FISH panels, the presence of subclones with additional cytogenetic aberrations (trisomy 8 in three patients and gain of a marker chromosome characterized by the centromere of chromosome 4 in a fourth patient) was assessed using single-cell resolution. The progenitor and immature myeloid compartments had the original founding clones containing a single cytogenetic abnormality at 15-34% and the subclones with the additional aberrations at 23-76%. In contrast, the mature myeloid cells were comprised of the original clone at 20-40%, but the subclones with additional aberrations were absent in the mature myeloid compartment in three patients and reduced by more than half in a fourth. For three patients sorted bone-marrow fractions were analyzed by SNP/CGH microarray. In one patient with trisomy 8 as the sole abnormality, the same aberration was observed in both the immature and mature myeloid compartments. In two other patients, additional abnormalities not seen in the mature myeloid cells were detected in the progenitor and immature myeloid compartments. Conclusions: These data show two main patterns for the distribution of clonal cytogenetic abnormalities among myeloid cells in MDS: 1) A continuous distribution at all stages of maturation was found for single aberrations with good-to-intermediate prognostic associations (Group 1) and 2) A disrupted distribution pattern with accumulation of the cytogenetic aberrations in the progenitor compartment as compared to the immature and mature myeloid compartments for specimens characterized by monosomy 7 (Group 2). Similarly, subclones characterized by additional cytogenetic abnormalities (Group 3) were sequestered in the progenitor and immature myeloid compartments while the original founding clone was evenly distributed throughout maturation. These data demonstrate that specific cytogenetic abnormalities associated with poor prognosis (e.g. monosomy 7) as well as acquired cytogenetic abnormalities as a result of clonal evolution can cause disruption of myeloid cell maturation in MDS. Disclosures Zehentner: HematoLogics Inc.: Employment, Equity Ownership. Hartmann:Hematologics Inc.: Employment. Johnson:Hematologics Inc.: Employment. Bennington:HematoLogics Inc.: Employment. Fritschle:HematoLogics Inc.: Employment. Ghirardelli:HematoLogics Inc.: Employment. Broderson:HematoLogics Inc.: Employment. Chapman:Hematologics Inc.: Employment. Stephenson:Hematologics Inc.: Employment. de Baca:Hematologics Inc.: Employment. Singleton:Hematologics Inc.: Employment. Wells:HematoLogics Inc.: Employment, Equity Ownership. Loken:Hematologics: Employment, Equity Ownership." @default.
- W2553981149 created "2016-11-30" @default.
- W2553981149 creator A5001870517 @default.
- W2553981149 creator A5034502014 @default.
- W2553981149 creator A5037555349 @default.
- W2553981149 creator A5040107457 @default.
- W2553981149 creator A5042806188 @default.
- W2553981149 creator A5043770886 @default.
- W2553981149 creator A5046839261 @default.
- W2553981149 creator A5055717516 @default.
- W2553981149 creator A5062261207 @default.
- W2553981149 creator A5063746286 @default.
- W2553981149 creator A5072740647 @default.
- W2553981149 creator A5081184705 @default.
- W2553981149 creator A5084550885 @default.
- W2553981149 creator A5086155515 @default.
- W2553981149 date "2014-12-06" @default.
- W2553981149 modified "2023-09-28" @default.
- W2553981149 title "Myeloid Cell Maturation Is Disrupted By Monosomy 7 or By Gain of Additional Genetic Aberrations during Clonal Evolution in Myelodysplastic Syndromes." @default.
- W2553981149 doi "https://doi.org/10.1182/blood.v124.21.3244.3244" @default.
- W2553981149 hasPublicationYear "2014" @default.
- W2553981149 type Work @default.
- W2553981149 sameAs 2553981149 @default.
- W2553981149 citedByCount "0" @default.
- W2553981149 crossrefType "journal-article" @default.
- W2553981149 hasAuthorship W2553981149A5001870517 @default.
- W2553981149 hasAuthorship W2553981149A5034502014 @default.
- W2553981149 hasAuthorship W2553981149A5037555349 @default.
- W2553981149 hasAuthorship W2553981149A5040107457 @default.
- W2553981149 hasAuthorship W2553981149A5042806188 @default.
- W2553981149 hasAuthorship W2553981149A5043770886 @default.
- W2553981149 hasAuthorship W2553981149A5046839261 @default.
- W2553981149 hasAuthorship W2553981149A5055717516 @default.
- W2553981149 hasAuthorship W2553981149A5062261207 @default.
- W2553981149 hasAuthorship W2553981149A5063746286 @default.
- W2553981149 hasAuthorship W2553981149A5072740647 @default.
- W2553981149 hasAuthorship W2553981149A5081184705 @default.
- W2553981149 hasAuthorship W2553981149A5084550885 @default.
- W2553981149 hasAuthorship W2553981149A5086155515 @default.
- W2553981149 hasConcept C104317684 @default.
- W2553981149 hasConcept C109748351 @default.
- W2553981149 hasConcept C113968399 @default.
- W2553981149 hasConcept C124942203 @default.
- W2553981149 hasConcept C142724271 @default.
- W2553981149 hasConcept C153911025 @default.
- W2553981149 hasConcept C174475383 @default.
- W2553981149 hasConcept C203014093 @default.
- W2553981149 hasConcept C2776229224 @default.
- W2553981149 hasConcept C2777542201 @default.
- W2553981149 hasConcept C2779142324 @default.
- W2553981149 hasConcept C2779282312 @default.
- W2553981149 hasConcept C2779672484 @default.
- W2553981149 hasConcept C2780007613 @default.
- W2553981149 hasConcept C2780189214 @default.
- W2553981149 hasConcept C2780365373 @default.
- W2553981149 hasConcept C2780817109 @default.
- W2553981149 hasConcept C30481170 @default.
- W2553981149 hasConcept C502942594 @default.
- W2553981149 hasConcept C53226629 @default.
- W2553981149 hasConcept C54355233 @default.
- W2553981149 hasConcept C71924100 @default.
- W2553981149 hasConcept C86803240 @default.
- W2553981149 hasConceptScore W2553981149C104317684 @default.
- W2553981149 hasConceptScore W2553981149C109748351 @default.
- W2553981149 hasConceptScore W2553981149C113968399 @default.
- W2553981149 hasConceptScore W2553981149C124942203 @default.
- W2553981149 hasConceptScore W2553981149C142724271 @default.
- W2553981149 hasConceptScore W2553981149C153911025 @default.
- W2553981149 hasConceptScore W2553981149C174475383 @default.
- W2553981149 hasConceptScore W2553981149C203014093 @default.
- W2553981149 hasConceptScore W2553981149C2776229224 @default.
- W2553981149 hasConceptScore W2553981149C2777542201 @default.
- W2553981149 hasConceptScore W2553981149C2779142324 @default.
- W2553981149 hasConceptScore W2553981149C2779282312 @default.
- W2553981149 hasConceptScore W2553981149C2779672484 @default.
- W2553981149 hasConceptScore W2553981149C2780007613 @default.
- W2553981149 hasConceptScore W2553981149C2780189214 @default.
- W2553981149 hasConceptScore W2553981149C2780365373 @default.
- W2553981149 hasConceptScore W2553981149C2780817109 @default.
- W2553981149 hasConceptScore W2553981149C30481170 @default.
- W2553981149 hasConceptScore W2553981149C502942594 @default.
- W2553981149 hasConceptScore W2553981149C53226629 @default.
- W2553981149 hasConceptScore W2553981149C54355233 @default.
- W2553981149 hasConceptScore W2553981149C71924100 @default.
- W2553981149 hasConceptScore W2553981149C86803240 @default.
- W2553981149 hasLocation W25539811491 @default.
- W2553981149 hasOpenAccess W2553981149 @default.
- W2553981149 hasPrimaryLocation W25539811491 @default.
- W2553981149 hasRelatedWork W13281853 @default.
- W2553981149 hasRelatedWork W1568313177 @default.
- W2553981149 hasRelatedWork W1708749080 @default.
- W2553981149 hasRelatedWork W1741176048 @default.
- W2553981149 hasRelatedWork W1991069555 @default.
- W2553981149 hasRelatedWork W2055663166 @default.
- W2553981149 hasRelatedWork W2104082514 @default.
- W2553981149 hasRelatedWork W217622729 @default.
- W2553981149 hasRelatedWork W2221252373 @default.
- W2553981149 hasRelatedWork W2406168547 @default.
- W2553981149 hasRelatedWork W2408966530 @default.
- W2553981149 hasRelatedWork W2416327601 @default.